Welcome & Introduction

Lorlatinib as front Line option in ALK+ mNSCLC

Meeting the unmet need in NSCLC patients with MET exon 14 alterations

Thymomas & Thymic carcinoma Pathology Classification and HC

Thymoma & Thymic Carcinoma Role of Surgery

Thymic neoplasms

Role of Radiation in Thymoma and Thymic carcinoma

Panel Discussion - Thymoma Thymic Carcinoma

Mesothelioma Diagnosis and Response Assessment

Surgery in Pleural Mesothelioma

Systemic therapy in Mesothelioma chemotherapy & immunotherapy recent advances

Role of RT Malignant Pleural Mesothelioma

Panel Discussion on Mesothelioma

Closing Remarks